MAPT and Parkinson disease: For the PD family shown in Fig. 1b, the most important dominant biomarker is α-synuclein, whose dominance (44.9%) is more than double that of individual Aβ1–40 (16.8%), Aβ1–42 (15.7%) and T-Tau (13.2%).